Eton Pharmaceuticals (ETON) Total Debt (2020 - 2025)
Historic Total Debt for Eton Pharmaceuticals (ETON) over the last 6 years, with Q3 2025 value amounting to $30.4 million.
- Eton Pharmaceuticals' Total Debt rose 63616.97% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.4 million, marking a year-over-year increase of 63616.97%. This contributed to the annual value of $29.8 million for FY2024, which is 45410.78% up from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' Total Debt is $30.4 million, which was up 63616.97% from $30.2 million recorded in Q2 2025.
- Eton Pharmaceuticals' Total Debt's 5-year high stood at $30.4 million during Q3 2025, with a 5-year trough of $364000.0 in Q2 2022.
- In the last 5 years, Eton Pharmaceuticals' Total Debt had a median value of $1.5 million in 2023 and averaged $7.0 million.
- As far as peak fluctuations go, Eton Pharmaceuticals' Total Debt crashed by 5140.19% in 2022, and later soared by 63616.97% in 2025.
- Eton Pharmaceuticals' Total Debt (Quarter) stood at $1.4 million in 2021, then fell by 27.15% to $1.0 million in 2022, then skyrocketed by 420.81% to $5.4 million in 2023, then surged by 454.11% to $29.8 million in 2024, then grew by 1.87% to $30.4 million in 2025.
- Its Total Debt stands at $30.4 million for Q3 2025, versus $30.2 million for Q2 2025 and $29.8 million for Q4 2024.